Medelis

Medelis is a specialty oncology contract research organization (CRO) that provides strategic planning and management for Phase I through Phase IV clinical trials. The company focuses exclusively on oncology and hematology, leveraging a team of clinical trial experts and medical monitors to design and execute complex cancer studies. Medelis offers a comprehensive suite of services including protocol development, site selection, data management, and regulatory support. In 2019, the company was acquired by WCCT Global to expand its early-phase clinical capabilities, and it now operates as a specialized oncology unit within the Altasciences group.